Print

AMRAD Corporation Limited (AML.AX) And Merck & Co., Inc. (MRK) Select Lead Antibody For Asthma 
10/19/2005 5:09:09 PM

17/08/2005 14:50:23 Melbourne-based Amrad (ASX:AML) and research partner Merck & Co have selected a lead therapeutic antibody for full preclinical development as a potential treatment for asthma and other types of respiratory disease.